Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CD34 may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. Additionally we are shipping CD34 Kits (31) and CD34 Proteins (31) and many more products for this protein.
Showing 10 out of 993 products:
Human Polyclonal CD34 Primary Antibody for FACS, IF (cc) - ABIN676898
Zigdon-Giladi, Lewinson, Bick, Machtei: Mesenchymal stem cells combined with barrier domes enhance vertical bone formation. in Journal of clinical periodontology 2013
Show all 21 references for 676898
Human Polyclonal CD34 Primary Antibody for FACS, IF (p) - ABIN671361
Long, Qiu, Liu, Fei, Feng, Wang, Zhong, Yi, Liu, Zhang, Han: Functional recovery and neuronal regeneration of a rat model of epilepsy by transplantation of Hes1-down regulated bone marrow stromal cells. in Neuroscience 2012
Show all 12 references for 671361
Mouse (Murine) Monoclonal CD34 Primary Antibody for FACS - ABIN119265
Garlanda, Berthier, Garin, Stoppacciaro, Ruco, Vittet, Gulino, Matteucci, Mantovani, Vecchi, Dejana: Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors. in European journal of cell biology 1997
Show all 5 references for 119265
Mouse (Murine) Monoclonal CD34 Primary Antibody for FACS, IHC (p) - ABIN119262
Winding, NicAmhlaoibh, Misander, Høegh-Andersen, Andersen, Holst-Hansen, Heegaard, Foged, Brünner, Delaissé: Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. in Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Show all 4 references for 119262
Human Monoclonal CD34 Primary Antibody for FACS, IHC (fro) - ABIN118603
Fina, Molgaard, Robertson, Bradley, Monaghan, Delia, Sutherland, Baker, Greaves: Expression of the CD34 gene in vascular endothelial cells. in Blood 1990
Show all 4 references for 118603
Mouse (Murine) Monoclonal CD34 Primary Antibody for FACS, IP - ABIN119264
Chen, Zeng, Wang, Briggs, ONeill, Li, Leek, Kerr, Harris, Cai: Roles of tetrahydrobiopterin in promoting tumor angiogenesis. in The American journal of pathology 2010
Show all 4 references for 119264
Human Polyclonal CD34 Primary Antibody for FACS, IF (p) - ABIN1713693
Cui, Zheng, Gong, Wen, Ma, Zhou, Zhang: Effects of Bu-Shen-An-Tai recipe and its two components on endometrial morphology during peri-implantation in superovulated mice. in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2014
Show all 2 references for 1713693
Human Monoclonal CD34 Primary Antibody for FACS, IHC (fro) - ABIN118600
Sopper, Stahl-Hennig, Demuth, Johnston, Dörries, ter Meulen: Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. in Cytometry 1998
Show all 2 references for 118600
Human Polyclonal CD34 Primary Antibody for FACS, IF (p) - ABIN671368
Yu, Wang, Wang, Lu, Li, Qin, Huang: Activation of liver X receptor enhances the proliferation and migration of endothelial progenitor cells and promotes vascular repair through PI3K/Akt/eNOS signaling pathway activation. in Vascular pharmacology 2014
sca-1 (show Ly6a Antibodies) antibody reduces both CD34+/c-kit (show KIT Antibodies)+ progenitor cell surge and vascular restenosis after endoluminal vascular injury in a murine model.
Aging induces loss of stemness with concomitant gain of myogenic properties of a pure population of CD34+/CD45 (show PTPRC Antibodies)- muscle derived stem cells.
Stem cell factor (show KITLG Antibodies) is essential for preserving reconstitution capacity of ex vivo expanded cord blood CD34(+) cells in Immunocompromised mice.
combinatorial expression of CD105 and CD34 receptors controls bone morphogenetic protein responsiveness in adipose-derived stem cells
Our results suggest that CD34+ cells may represent the adipose-derived mesenchymal stem cells which possess stronger multiple differentiation potential during reconstituted skin development
Data suggest that CD34 may be a specific marker for functionality, with some specificity for insulin (show INS Antibodies).
murine in vitro expanded bone marrow-derived murine mesenchymal stem cells can transform into CD34 expressing cells that induce sarcoma formation in vivo.
Blood-borne CD34(+) endothelial progenitor cells, characterized by active cell division and an amplified transcriptional signature, transition into resident endothelial cells during compensatory lung growth.
CD34 is necessary for efficient muscle regeneration in adult mice.
We conclude that CD34 is expressed by mucosal Dendritic Cells and plays an important role in their trafficking through the lung and to the lymph nodes.
Intramyocardial autologous CD34(+) cell administration improved exercise tolerance in patients with refractory angina.
Increased gene expression linked to the proinflammatory TGFbeta (show TGFB1 Antibodies) and MAPK (show MAPK1 Antibodies) signaling pathways were detected in CD34(+) cells of myeloproliferative neoplasm patients.
CD34 stem cell exosomes mediate ischemic tissue repair via beneficial angiogenesis. Exosome-shuttled proangiogenic miRNAs may amplify stem cell function.
miR (show MLXIP Antibodies)-378 regulates the angiogenic capacity of CD34(+) progenitor cells in STEMI patients.
CD34 and IL-8 (show IL8 Antibodies) are associated with poor prognosis of melanoma, metastasis, and neoangiogenesis
The results showed that transfection of CD34(+) cells with SiRNA targeting TGF-bRII and their co-culture with human bone marrow mesenchymal stromal cells (MSCs) could considerably increase the number of progenitors
Expression of CD34 and MMP-9 (show MMP9 Antibodies) accurately predicts clinical behavior detection and prognosis of GCTBs.
Expression of VEGF (show VEGFA Antibodies) and CD34 was critically correlated with perioperative hemorrhage in gastric cancer patients.
There was significant correlation between age and tumor size with CD34 expression in oral SCC (show CYP11A1 Antibodies) samples and no significant correlation between sex and tumor differentiation level. Also, there was no significant correlation between age, sex, tumor size and tumor differentiation level (grading) with CD34 expression in esophagus SCC (show CYP11A1 Antibodies) samples.
Normal FLT3 (show FLT3 Antibodies) and negative expression of CD34 and cMPL (show MPL Antibodies) may predict a longer overall survival in aute myeloid leukemia (show BCL11A Antibodies).
There is an association with CD34 immunostaining and ischemic injury of pedicle flaps.
These results suggest that CD34 may be involved in mediating the cell-to-cell adhesion between trophectoderm and the luminal epithelial cells during early pregnancy in pigs.
Combination of anti-CD34 antibody and drug-eluting stents reduces risk of coronary restenosis.
Immobilization of anti-CD34 antibody on sirolimus-eluting stents enhances endothelialization and may potentially be an effective therapeutic alternative to improve currently available drug-eluting stents.
The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene.
, cluster designation 34
, hematopoietic progenitor cell antigen CD34
, hematopoietic progenitor cell marker CD34